Evidence map›Paper›PMID 31946282›Full record

ArticleAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2019

Pathogenic Processes Underlying Alzheimer's Disease: Modeling the Effects of Amyloid Beta on Synaptic Transmission.

Jean-Marie C Bouteiller, Adam R Mergenthal, Eric Hu, Theodore W Berger

Open access · greenAbstract read
In one paragraph

Article in Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Hallmarks of neurodegenerative disease: A systems pharmacology perspective.CPT: pharmacometrics & systems pharmacology · 2022
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jean-Marie C Bouteiller
Adam R Mergenthal
Eric Hu
Theodore W Berger
University of Southern California · US

Funding

TrainingP41EB001978 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KHOO, MICHAEL C K · 2003 to 2017
$18.1M
Predictive modeling of bioelectric activity on mammalian multilayered neuronal stU01GM104604 · NIGMS · UNIVERSITY OF UTAH · PI BERGER, THEODORE W., LAZZI, GIANLUCA · 2012 to 2016
$2.8M
PREDICTIVE MODELING OF BIOELECTRIC ACTIVITY ON MAMMALIAN MULTILAYERED NEURONAL STRUCTURES IN THE PRESENCE OF SUPRAPHYSIOLOGICAL ELECTRIC FIELDSU01EB025830 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGER, THEODORE W., LAZZI, GIANLUCA · 2018 to 2021
$2.7M
NIBIB NIH HHS P41 EB001978NIBIB NIH HHS U01 EB025830NIGMS NIH HHS U01 GM104604
6 · The paper itself

Abstract

The molecular mechanisms underlying Alzheimer's disease (AD) have been and are still under heavy scrutiny to better understand what leads to the onset and progression of the disease, and to design and develop efficacious therapeutic strategies. These decade-long studies have taught us a lot regarding the various molecular pathways involved in the pathology, but a complete dynamic picture of the underlying pathological mechanisms is still missing.We propose to provide a technological answer to fill this gap by developing and using a computational approach that integrates AD-related experimental findings and their effects on multiple aspects of neuronal function. The present study focuses on implementing one known pathogenic process: the binding of amyloid beta, the hallmark of AD, on NMDA receptors, receptors present in the main type of excitatory synapses in the brain, thereby affecting synaptic transmission and downstream pathways. We describe model implementation and calibration; we then quantify the downstream effects of this disruption both in terms of electrical activity (changes in short-term spiking activity of the postsynaptic neuron), and biochemical pathways activation through changes in calcium dynamics (an important trigger to longer-term changes). The computational approach outlined constitutes an insightful instrument to examine the downstream consequences of multiple pathogenic dysfunctions on higher level observables and sets the path for in-silico discovery and testing of therapeutic agents.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesSynaptic TransmissionHumansModels, TheoreticalReceptors, N-Methyl-D-AspartateSynapsesAmyloid beta-PeptidesReceptors, N-Methyl-D-Aspartate

Identifiers

PMID31946282
PMCPMC7039439
OpenAlexW2980145284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.